Immunogenic targets for specific immunotherapy in multiple myeloma - Wikidata - awgldk - TriplyDB

Immunogenic targets for specific immunotherapy in multiple myeloma

Immunogenic targets for specific immunotherapy in multiple myeloma

http://www.wikidata.org/entity/Q26859007

about

Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.T cell-based targeted immunotherapies for patients with multiple myeloma.A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma.

P2860

Q38134763-7BEC7FE8-2937-4B70-A053-F6A4CDD854EA Q38246639-2BC767BB-8FF3-4630-A158-2E1781B6AC46 Q47829053-5283E319-76B8-4B29-A5F0-D4B797C4DBF2 Q48507398-AB366DD5-705B-4691-AE84-ACAAEC51D871

P2860

Immunogenic targets for specific immunotherapy in multiple myeloma

http://www.wikidata.org/entity/Q26859007

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Immunogenic targets for specific immunotherapy in multiple myeloma

@ast

Immunogenic targets for specific immunotherapy in multiple myeloma

@en

Immunogenic targets for specific immunotherapy in multiple myeloma

@nl

type

label

Immunogenic targets for specific immunotherapy in multiple myeloma

@ast

Immunogenic targets for specific immunotherapy in multiple myeloma

@en

Immunogenic targets for specific immunotherapy in multiple myeloma

@nl

prefLabel

Immunogenic targets for specific immunotherapy in multiple myeloma

@ast

Immunogenic targets for specific immunotherapy in multiple myeloma

@en

Immunogenic targets for specific immunotherapy in multiple myeloma

@nl

P1433

Q26859007-D3A9EE0F-38A0-46AC-B370-CBC8AC89A809

P1476

Q26859007-8408D0B7-23E3-4ED5-9D3D-6EA78255A4D5

P2093

Q26859007-43EA379B-600D-46C0-8451-061245B14EBF

Q26859007-B3A73EC8-6CD1-4886-90A9-F69D3269A923

Q26859007-CDC7E387-8B23-4970-BA24-2208D5DAA608

Q26859007-D347AA43-B1F5-43EC-AB6B-82A35542AF41

P275

Q26859007-2BF3F15A-7BC4-4A97-AB21-4EE68FB563CE

P2860

Q26859007-0870192E-9125-450F-A1A7-8D1AD2BE648E

Q26859007-08E23927-D6E5-49C3-91E2-2D0BF0EB9B51

Q26859007-0E0BD968-31BB-4E54-897F-B85685EF41C9

Q26859007-0E862F04-904C-46B5-8ADD-B546AA426D63

Q26859007-11A2898A-A59F-416E-865D-0D30C98CCA4E

Q26859007-11EEFC16-B93E-4124-BF96-479EB9ABDDA5

Q26859007-1DC37525-224D-409F-8749-3B599C9D0E98

Q26859007-22D04C2A-27EA-4A10-922A-628A3129798D

Q26859007-29D2B345-9125-400A-BFA0-CCC1F2E39AD6

Q26859007-2C7D3DC8-1969-4922-BD4C-86FFAFBD449A

P304

Q26859007-68F0EC35-60C8-404E-AFB6-584B07A0EBCD

P31

Q26859007-8F9519D6-A127-4FE5-858D-39F52EC288E7

Q26859007-9F32F287-8A02-4AD2-9FD1-33BEC74E5458

P356

Q26859007-95A86532-9EF7-4C85-A424-FB0981937BFC

P407

Q26859007-8B8BFCCE-E555-4E8C-B7B8-90F75B700070

P478

Q26859007-2B154FF3-E146-4EF5-8648-F9E321544755

P5008

Q26859007-026E2CA6-4366-4E36-9983-927208DBB2F4

P577

Q26859007-82176D24-EA7A-4995-99AF-2875F4E7BA75

Q26859007-BE76A7F9-F170-48A0-AD47-FE6CB297F759

P5875

Q26859007-1E36BF69-6917-4CD7-9B4A-EDD0EB71FD5B

P698

Q26859007-93A73BFB-546D-40A0-8075-C3A699EA8A0F

P921

Q26859007-3D9399A1-1EEC-4B15-A8ED-37C38DEB28AC

Q26859007-41EA1ECF-79B7-42F8-92F7-2487F0B7299C

Q26859007-F994319E-E7AC-4518-96B6-F609B69E9792

P932

Q26859007-661EC92F-F6EA-491A-8AB0-233D3F6B52E1

P356

P1433

Clinical and Developmental Immunology

P1476

Immunogenic targets for specific immunotherapy in multiple myeloma

@en

P2093

Jochen Greiner

http://www.w3.org/2001/XMLSchema#string

Lu Zhang

http://www.w3.org/2001/XMLSchema#string

Marlies Götz

http://www.w3.org/2001/XMLSchema#string

Susanne Hofmann

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Functional and structural diversity of the human Dickkopf gene family

A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer-testis antigen in hematologic malignancies

Cancer statistics, 2010

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

Cancer immunotherapy comes of age

Rituximab in indolent lymphomas.

P304

820394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/820394

http://www.w3.org/2001/XMLSchema#string

P407

P478

2012

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225050783

http://www.w3.org/2001/XMLSchema#string

P698

22611422

http://www.w3.org/2001/XMLSchema#string

P921

multiple myeloma

biomedical investigative technique

P932

3352660

http://www.w3.org/2001/XMLSchema#string